| USD ($) $ in Thousands | LTM | Nov 1, 2025 | Nov 2, 2024 | Oct 28, 2023 | Oct 29, 2022 | Oct 30, 2021 | Oct 31, 2020 | Nov 2, 2019 | Nov 3, 2018 | Oct 28, 2017 | Oct 29, 2016 | Oct 31, 2015 | Nov 1, 2014 | Nov 2, 2013 | Nov 3, 2012 | Oct 29, 2011 | Oct 30, 2010 | Oct 31, 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||||||||||||||
Net income | $ 4,135,004 | $ 2,267,342 | $ 1,635,273 | $ 3,314,579 | ||||||||||||||
Adjustments to reconcile net income to net cash provided by operations: | ||||||||||||||||||
Depreciation | 420,776 | 406,801 | 362,771 | 334,704 | ||||||||||||||
Amortization of intangibles | 1,550,223 | 1,592,044 | 1,741,545 | 1,958,399 | ||||||||||||||
Cost of goods sold for inventory acquired | - | - | 0 | 0 | ||||||||||||||
Stock-based compensation expense | 350,103 | 321,560 | 262,710 | 299,823 | ||||||||||||||
Gain on sale of property, plant and equipment | - | - | - | - | ||||||||||||||
Non-cash contribution to charitable foundation | - | - | - | - | ||||||||||||||
Net Gain on Sale of Product line | - | - | - | - | ||||||||||||||
Gain on sale of business | - | - | - | - | ||||||||||||||
Gain on sale of investments | - | - | - | - | ||||||||||||||
Gain on Sale of Product Line | - | - | - | - | ||||||||||||||
Loss on extinguishment of debt | - | - | - | 0 | ||||||||||||||
Non-cash impairment charge | - | - | 0 | 0 | ||||||||||||||
Deferred income taxes | (431,268) | (246,645) | (367,563) | (452,946) | ||||||||||||||
Non-cash operating lease costs | - | - | - | - | ||||||||||||||
Non-cash portion of special charges | - | - | - | - | ||||||||||||||
Minority interest | - | - | - | - | ||||||||||||||
Non-cash portion of special charges | - | - | - | - | ||||||||||||||
Other | (27,790) | (9,909) | 23,050 | 8,665 | ||||||||||||||
Excess tax benefit — equity based awards | - | - | - | - | ||||||||||||||
Change in operating assets and liabilities: | ||||||||||||||||||
Accounts receivable | (90,960) | (90,960) | 133,402 | 330,728 | ||||||||||||||
Inventories | (208,636) | (208,636) | 191,170 | (242,299) | ||||||||||||||
Prepaid expenses and other current assets | 9,107 | 9,107 | (53,004) | 4,543 | ||||||||||||||
Deferred compensation plan investments | - | - | - | - | ||||||||||||||
Prepaid income tax | - | - | - | - | ||||||||||||||
Accounts payable and accrued liabilities | 657,305 | 657,305 | (133,758) | (499,316) | ||||||||||||||
Income tax payments related to gain on sale of businesses | - | - | - | - | ||||||||||||||
Income taxes payable | 94,303 | 94,303 | 91,648 | (263,716) | ||||||||||||||
Accounts payable, deferred income and accrued liabilities | - | - | - | - | ||||||||||||||
(Decrease) increase in accounts payable, deferred income and accrued liabilities | - | - | - | - | ||||||||||||||
Deferred compensation plan liability | - | - | - | - | ||||||||||||||
Income taxes payable, current | - | - | - | - | ||||||||||||||
Other assets | 6,664 | 6,664 | (34,521) | (25,819) | ||||||||||||||
Other liabilities | 13,226 | 13,226 | (194) | 50,289 | ||||||||||||||
Total adjustments | 1,410,321 | 2,544,860 | 2,217,256 | 1,503,055 | ||||||||||||||
Net cash provided by operating activities | 5,545,325 | 4,812,202 | 3,852,529 | 4,817,634 | ||||||||||||||
Investing Activities | ||||||||||||||||||
Cash flows from investing activities: | ||||||||||||||||||
Purchases of short-term available-for-sale investments | 0 | (1,150,240) | - | - | ||||||||||||||
Maturities of short-term available-for-sale investments | 990,657 | 372,778 | - | - | ||||||||||||||
Purchases of short-term investments | - | - | (438,901) | - | ||||||||||||||
Maturities of short-term investments | - | - | 69,279 | - | ||||||||||||||
Sales of short-term available-for-sale investments | - | - | - | - | ||||||||||||||
Additions to property, plant and equipment, net | (607,830) | (533,552) | (730,463) | (1,261,463) | ||||||||||||||
Cash received from acquisition of Maxim, net of cash paid | - | - | - | - | ||||||||||||||
Proceeds from sale of property, plant and equipment, net | 0 | 58,892 | - | - | ||||||||||||||
Net proceeds related to sale of businesses | - | - | - | - | ||||||||||||||
Proceeds related to sale of investments | - | - | - | - | ||||||||||||||
Proceeds from Divestiture of Businesses | - | - | - | - | ||||||||||||||
Cash received from acquisition of Maxim, net of cash paid | (1,536,049) | (45,652) | - | 0 | ||||||||||||||
Other | (42,577) | (23,747) | (4,773) | (4,922) | ||||||||||||||
Change in other assets | - | - | - | - | ||||||||||||||
Net cash used for investing activities | (1,099,207) | (1,321,521) | (1,104,858) | (1,266,385) | ||||||||||||||
Financing Activities | ||||||||||||||||||
Cash flows from financing activities: | ||||||||||||||||||
Proceeds from debt | 0 | 1,490,785 | 1,087,856 | 0 | ||||||||||||||
Early termination of debt | 0 | 0 | 0 | (65,688) | ||||||||||||||
Debt repayments | 0 | (399,998) | (499,966) | - | ||||||||||||||
Payments on revolver | - | - | 0 | 0 | ||||||||||||||
Proceeds from revolver | - | - | 0 | 0 | ||||||||||||||
Proceeds from commercial paper notes | 15,656,381 | 9,462,691 | 10,184,439 | 5,287,124 | ||||||||||||||
Payments of commercial paper notes | (15,199,941) | (9,563,790) | (10,183,925) | (4,739,900) | ||||||||||||||
Proceeds from long-term debt | - | - | - | - | ||||||||||||||
Payment on derivative instrument | - | - | - | 0 | ||||||||||||||
Prepayment for stock repurchases | - | - | - | 0 | ||||||||||||||
Proceeds from derivative instruments | - | - | - | - | ||||||||||||||
Proceeds from (payments of) derivative instruments | - | - | - | - | ||||||||||||||
Payments of deferred financing fees | - | - | - | - | ||||||||||||||
Early termination of swap agreements | - | - | - | - | ||||||||||||||
ProceedsFromDerivativeInstruments | - | - | - | - | ||||||||||||||
Payment of senior unsecured notes | - | - | - | - | ||||||||||||||
Term Loan Repayments | - | - | - | - | ||||||||||||||
Proceeds from issuance of long-term debt | - | - | - | - | ||||||||||||||
Dividend payments to shareholders | (2,042,920) | (1,924,413) | (1,795,459) | (1,679,106) | ||||||||||||||
Repurchase of common stock | (3,126,881) | (2,164,638) | (615,590) | (2,963,955) | ||||||||||||||
Proceeds from employee stock plans | 125,755 | 108,913 | 121,215 | 118,608 | ||||||||||||||
Contingent consideration payment | - | - | - | - | ||||||||||||||
Other | (13,833) | 7,833 | (12,960) | (20,843) | ||||||||||||||
Excess tax benefit — equity based awards | - | - | - | - | ||||||||||||||
Net cash used for financing activities | (4,601,439) | (2,982,617) | (1,714,390) | (4,063,760) | ||||||||||||||
Effect of exchange rate changes on cash | - | - | 0 | 0 | ||||||||||||||
Net increase (decrease) in cash and cash equivalents | $ (155,321) | $ 508,064 | $ 1,033,281 | $ (512,511) |